These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22967783)

  • 21. Modafinil: new indication. For a minority of patients with sleep apnoea.
    Prescrire Int; 2007 Jun; 16(89):102-3. PubMed ID: 17582924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with sleep apnea.
    Nikolaou A; Schiza SE; Giakoumaki SG; Roussos P; Siafakas N; Bitsios P
    Psychopharmacology (Berl); 2008 Feb; 196(2):167-75. PubMed ID: 17899016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the safety of modafinil for treatment of excessive sleepiness.
    Roth T; Schwartz JR; Hirshkowitz M; Erman MK; Dayno JM; Arora S
    J Clin Sleep Med; 2007 Oct; 3(6):595-602. PubMed ID: 17993041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obstructive sleep apnea, hypertension, and wakefulness-promoting agents.
    Carl D; Sica DA
    Curr Hypertens Rep; 2007 Aug; 9(4):329-31. PubMed ID: 17686385
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of modafinil and clomipramine as comedication in a narcoleptic patient.
    Grözinger M; Härtter S; Hiemke C; Griese EU; Röschke J
    Clin Neuropharmacol; 1998; 21(2):127-9. PubMed ID: 9579300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
    George CF; Feldman N; Zheng Y; Steininger TL; Grzeschik SM; Lai C; Inhaber N
    Sleep Breath; 2011 Jan; 15(1):13-20. PubMed ID: 20082240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Armodafinil.
    Garnock-Jones KP; Dhillon S; Scott LJ
    CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
    Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro: modafinil has a role in management of sleep apnea.
    Black J
    Am J Respir Crit Care Med; 2003 Jan; 167(2):105-6; discussion 108. PubMed ID: 12524247
    [No Abstract]   [Full Text] [Related]  

  • 36. Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.
    Prado E; Paholpak P; Ngo M; Porter V; Apostolova LG; Marrocos R; Ringman JM
    Am J Alzheimers Dis Other Demen; 2012 Nov; 27(7):468-73. PubMed ID: 22892657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is psychosis exacerbated by modafinil?
    Narendran R; Young CM; Valenti AM; Nickolova MK; Pristach CA
    Arch Gen Psychiatry; 2002 Mar; 59(3):292-3. PubMed ID: 11879175
    [No Abstract]   [Full Text] [Related]  

  • 38. Why choose modafinil for excessive daytime sleepiness?
    Tobin ML
    Issues Ment Health Nurs; 2007 Mar; 28(3):313-7. PubMed ID: 17454283
    [No Abstract]   [Full Text] [Related]  

  • 39. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI; Black JE; Schwartz JR; Matheson JK
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1675-81. PubMed ID: 11719309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A follow-up study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Hardy T; MacDonald C; Jones DE; Newton JL
    Liver Int; 2010 Nov; 30(10):1551-2. PubMed ID: 20536714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.